These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29796012)

  • 21. Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness.
    Rheingans R; Atherly D; Anderson J
    Vaccine; 2012 Apr; 30 Suppl 1():A15-23. PubMed ID: 22520124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare system.
    Loganathan T; Jit M; Hutubessy R; Ng CW; Lee WS; Verguet S
    Trop Med Int Health; 2016 Nov; 21(11):1458-1467. PubMed ID: 27503549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using Economic Evidence to Set Healthcare Priorities in Low-Income and Lower-Middle-Income Countries: A Systematic Review of Methodological Frameworks.
    Wiseman V; Mitton C; Doyle-Waters MM; Drake T; Conteh L; Newall AT; Onwujekwe O; Jan S
    Health Econ; 2016 Feb; 25 Suppl 1(Suppl Suppl 1):140-61. PubMed ID: 26804361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
    Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
    Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventions to improve access to cataract surgical services and their impact on equity in low- and middle-income countries.
    Ramke J; Petkovic J; Welch V; Blignault I; Gilbert C; Blanchet K; Christensen R; Zwi AB; Tugwell P
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011307. PubMed ID: 29119547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating health inequality impact into economic evaluation in low- and middle-income countries: a systematic review.
    Yang F; Katumba KR; Griffin S
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jan; 22(1):17-25. PubMed ID: 34263710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiological and Economic Impact of Monovalent and Pentavalent Rotavirus Vaccines in Low and Middle Income Countries: A Cost-effectiveness Modeling Analysis.
    Paternina-Caicedo A; De la Hoz-Restrepo F; Alvis-Guzmán N
    Pediatr Infect Dis J; 2015 Jul; 34(7):e176-84. PubMed ID: 25923424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan.
    Rheingans R; Anderson JD; Bagamian KH; Laytner LA; Pecenka CJ; Gilani SSA; Ahmed M
    Vaccine; 2018 Dec; 36(51):7780-7789. PubMed ID: 30007826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eliciting Trade-Offs Between Equity and Efficiency: A Methodological Scoping Review.
    Cadham CJ; Prosser LA
    Value Health; 2023 Jun; 26(6):943-952. PubMed ID: 36805575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of rotavirus vaccination in Albania.
    Ahmeti A; Preza I; Simaku A; Nelaj E; Clark AD; Felix Garcia AG; Lara C; Hoestlandt C; Blau J; Bino S
    Vaccine; 2015 May; 33 Suppl 1():A201-8. PubMed ID: 25919162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review.
    Ozawa S; Mirelman A; Stack ML; Walker DG; Levine OS
    Vaccine; 2012 Dec; 31(1):96-108. PubMed ID: 23142307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thresholds for decision-making: informing the cost-effectiveness and affordability of rotavirus vaccines in Malaysia.
    Loganathan T; Ng CW; Lee WS; Hutubessy RCW; Verguet S; Jit M
    Health Policy Plan; 2018 Mar; 33(2):204-214. PubMed ID: 29228339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimated impact and cost-effectiveness of rotavirus vaccination in India: effects of geographic and economic disparities.
    Rheingans R; Anderson JD; Anderson B; Chakraborty P; Atherly D; Pindolia D
    Vaccine; 2014 Aug; 32 Suppl 1():A140-50. PubMed ID: 25091669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
    Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the cost-effectiveness of child dental caries prevention programmes. Are we comparing apples and oranges?
    Anopa Y; Conway DI
    Evid Based Dent; 2020 Mar; 21(1):5-7. PubMed ID: 32221482
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.